Schmidt C, Scheubeck G, Jurinovic V, Sökler M, Forstpointner R, Buske C, Viardot A, Keller U, Graeven U, Marks R, Hänel M, Liersch R, Dürig J, Pott C, Hoster E, Unterhalt M, Hiddemann W. Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance. haematol [Internet]. 2025Dec.1 [cited 2025Dec.5];110(12):3022-31. Available from: https://haematologica.org/article/view/12104